Skip to content
24/7 Wall Street Logo
  • Investing
  • Personal Finance
  • Technology
  • Economy and Geopolitics
    • Economy
    • Politics
    • Crime
    • Infrastructure
    • Military

    Trending Articles

    Forget SMH. The Chip Fund That Owns Less Nvidia Is Beating It by 20 Points
    7 minutes ago

    Forget SMH. The Chip Fund That Owns Less Nvidia Is Beating It by 20 Points

    Bitcoin ETFs Are Having Their Best Week Since April. Did the Coldcard Hack Push $853M Into Bitcoin ETFs?
    37 minutes ago

    Bitcoin ETFs Are Having Their Best Week Since April. Did the Coldcard Hack Push $853M Into Bitcoin ETFs?

  • AI Portfolio
AI Investor Podcast
  • Investing
  • Personal Finance
  • Technology
  • Economy and Geopolitics
    • Economy
    • Politics
    • Crime
    • Infrastructure
    • Military
  • AI Portfolio
S&P 500
7,633.20
+0.31%
Dow Jones
53,893.00
+1.14%
Nasdaq 100
29,106.20
+0.99%
Russell 2000
2,995.41
+0.37%
FTSE 100
10,904.40
+0.20%
Nikkei 225
64,309.90
+1.28%

Investing

NMTR logo 9 Meters Biopharma Inc. : NMTR

NMTR

Stock Data

$0.00

Change up

$0.00 (0.00%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

All NMTR Articles

3 Articles

Blazing Biotechs Highlight Stocks Trading Under $10 With Massive Upside Potential
Lee Jackson | Jul 10, 2021 at 6:15 AM EDT

Blazing Biotechs Highlight Stocks Trading Under $10 With Massive Upside Potential

These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential.…

Thursday’s Top Analyst Upgrades and Downgrades: Charles Schwab, Datadog, Deere, Dish Network, Etsy, Freeport-McMoRan, Regions Financial and More
Lee Jackson | Jul 8, 2021 at 8:42 AM EDT

Thursday’s Top Analyst Upgrades and Downgrades: Charles Schwab, Datadog, Deere, Dish Network, Etsy, Freeport-McMoRan, Regions Financial and More

Thursday's top analyst upgrades and downgrades included Beyond Meat, Charles Schwab, Datadog, Deere, Dish Network, Etsy, Freeport-McMoRan and Regions Financial.

How Speculative Biotech 9 Meters Biopharma Could Rise Tenfold
Chris Lange | Jun 30, 2020 at 10:45 AM EDT

How Speculative Biotech 9 Meters Biopharma Could Rise Tenfold

9 Meters Biopharma may not be a household name right now, but one brokerage firm sees huge potential upside.

More Content
Forget SMH. The Chip Fund That Owns Less Nvidia Is Beating It by 20 Points
David Beren • Aug 8, 2026

Forget SMH. The Chip Fund That Owns Less Nvidia Is Beating It by 20 Points

Bitcoin ETFs Are Having Their Best Week Since April. Did the Coldcard Hack Push $853M Into Bitcoin ETFs?
Sam Daodu • Aug 8, 2026

Bitcoin ETFs Are Having Their Best Week Since April. Did the Coldcard Hack Push $853M Into Bitcoin ETFs?

She Asked an AI Chatbot When to Claim Social Security. It Sounded Certain, and It Was Wrong.
Gerelyn Terzo • Aug 8, 2026

She Asked an AI Chatbot When to Claim Social Security. It Sounded Certain, and It Was Wrong.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

She Asked an AI Chatbot When to Claim Social Security. It Sounded Certain, and It Was Wrong.
Gerelyn Terzo | 46 minutes ago

She Asked an AI Chatbot When to Claim Social Security. It Sounded Certain, and It Was Wrong.

'Your Anxiety Comes From Your Mother Being a Twerp': Dave Ramsey to Caller Who Paid Off $12K But Can't Shake Family Pressure
Michael Williams | 1 hour ago

'Your Anxiety Comes From Your Mother Being a Twerp': Dave Ramsey to Caller Who Paid Off $12K But Can't Shake Family Pressure

24/7 Wall St. logo
  • Home
  • About Us
  • Contact Us
  • Financial Tools
  • Disclaimer and Terms of Use
  • Privacy Policy
  • CCPA Privacy Policy
  • Advertise
© 2026 24/7 Wall St.